Insights

Innovative Therapeutics Adocia specializes in developing advanced formulations of approved therapeutic proteins, particularly focusing on diabetes and obesity, indicating opportunities to collaborate on cutting-edge treatments for metabolic diseases.

Emerging Market Presence Listed on Euronext with recent funding of 10 million USD and revenues under 1 million USD, Adocia presents a promising growth trajectory, ideal for strategic partnerships and investment opportunities to accelerate clinical and commercial expansion.

Technological Innovation The proprietary BioChaperone platform enhances therapeutic protein efficacy and safety, creating potential for partnerships in biologics advanced formulations and technological licensing deals.

Funding & Growth With recent capital injection and a focused pipeline, Adocia offers prospects for sales collaborations in bioscience tools, formulation services, and device integrations targeting biotech and pharma clients seeking innovative solutions.

Targeted Market Focus Specializing in metabolic disorders with a clear emphasis on patient-centric formulations suggests viable opportunities in medical device integration, patient adherence solutions, and personalized medicine approaches.

ADOCIA Tech Stack

ADOCIA uses 8 technology products and services including Open Graph, Google Fonts API, jQuery, and more. Explore ADOCIA's tech stack below.

  • Open Graph
    Content Management System
  • Google Fonts API
    Font Scripts
  • jQuery
    Javascript Libraries
  • jQuery Migrate
    Javascript Libraries
  • Modernizr
    Javascript Libraries
  • Slider Revolution
    Miscellaneous
  • OVHcloud
    Platform As A Service
  • reCAPTCHA
    Security

Media & News

ADOCIA's Email Address Formats

ADOCIA uses at least 1 format(s):
ADOCIA Email FormatsExamplePercentage
F.Last@adocia.comJ.Doe@adocia.com
85%
First.Last@adocia.comJohn.Doe@adocia.com
7%
Last@adocia.comDoe@adocia.com
6%
First@adocia.comJohn@adocia.com
2%

Frequently Asked Questions

What is ADOCIA's phone number?

Minus sign iconPlus sign icon
You can contact ADOCIA's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is ADOCIA's stock symbol?

Minus sign iconPlus sign icon
ADOCIA is a publicly traded company; the company's stock symbol is ADOIF.

What is ADOCIA's official website and social media links?

Minus sign iconPlus sign icon
ADOCIA's official website is adocia.com and has social profiles on LinkedInCrunchbase.

What is ADOCIA's SIC code NAICS code?

Minus sign iconPlus sign icon
ADOCIA's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does ADOCIA have currently?

Minus sign iconPlus sign icon
As of January 2026, ADOCIA has approximately 87 employees across 3 continents, including EuropeNorth AmericaSouth America. Key team members include Chief Financial Officer: V. D.Chief Representative: L. A.Head Of Business Strategy: J. B.. Explore ADOCIA's employee directory with LeadIQ.

What industry does ADOCIA belong to?

Minus sign iconPlus sign icon
ADOCIA operates in the Biotechnology Research industry.

What technology does ADOCIA use?

Minus sign iconPlus sign icon
ADOCIA's tech stack includes Open GraphGoogle Fonts APIjQueryjQuery MigrateModernizrSlider RevolutionOVHcloudreCAPTCHA.

What is ADOCIA's email format?

Minus sign iconPlus sign icon
ADOCIA's email format typically follows the pattern of F.Last@adocia.com. Find more ADOCIA email formats with LeadIQ.

How much funding has ADOCIA raised to date?

Minus sign iconPlus sign icon
As of January 2026, ADOCIA has raised $10M in funding. The last funding round occurred on Feb 26, 2025 for $10M.

When was ADOCIA founded?

Minus sign iconPlus sign icon
ADOCIA was founded in 2005.

ADOCIA

Biotechnology ResearchAuvergne-rhone-alpes, France51-200 Employees

"Innovative medicine for everyone, everywhere" 

Listed on the Euronext stock market, Adocia is a clinical-stage biotech company specialized in the development of best-in-class medicine relying on innovative formulations of already-approved therapeutic proteins. Adocia is specialized in diabetes and obesity. 

The proprietary BioChaperone® technological platform is designed to enhance the effectiveness and safety of therapeutic proteins and their ease of use for patients.

For more information, visit our website: www.adocia.com

For careers offers, please click to the following  link : https://www.adocia.com/careers/adocia-careers/

Section iconCompany Overview

Phone number
Website
adocia.com
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
ADOIF
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2005
Employees
51-200

Section iconMedia & News

Section iconFunding & Financials

  • $10M

    ADOCIA has raised a total of $10M of funding over 4 rounds. Their latest funding round was raised on Feb 26, 2025 in the amount of $10M.

  • $1M

    ADOCIA's revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $10M

    ADOCIA has raised a total of $10M of funding over 4 rounds. Their latest funding round was raised on Feb 26, 2025 in the amount of $10M.

  • $1M

    ADOCIA's revenue is estimated to be in the range of $1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.